- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aarti Pharmalabs Ltd (AARP)
Aarti Pharmalabs Ltd stock price live, this page displays NSE AARP stock exchange data. View the AARP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aarti Pharmalabs Ltd real time stock price chart below.
What Is the Aarti Pharmalabs Ltd Stock Price Today?
The Aarti Pharmalabs Ltd stock price today is 863.80.
What Is the Stock Symbol for Aarti Pharmalabs Ltd?
The stock symbol for Aarti Pharmalabs Ltd is "AARP."
What Stock Exchange Does Aarti Pharmalabs Ltd Trade On?
Aarti Pharmalabs Ltd is listed and trades on the NSE stock exchange.
Is Aarti Pharmalabs Ltd a Good Stock to Buy?
Determining whether Aarti Pharmalabs Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AARP quote. (ISIN: INE0LRU01027)
What Is the Aarti Pharmalabs Ltd Stock Price Today?
The Aarti Pharmalabs Ltd stock price today is 863.80.
What Is the Stock Symbol for Aarti Pharmalabs Ltd?
The stock symbol for Aarti Pharmalabs Ltd is "AARP."
What Stock Exchange Does Aarti Pharmalabs Ltd Trade On?
Aarti Pharmalabs Ltd is listed and trades on the NSE stock exchange.
Is Aarti Pharmalabs Ltd a Good Stock to Buy?
Determining whether Aarti Pharmalabs Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AARP quote. (ISIN: INE0LRU01027)
863.80
-3.85(-0.44%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
858.00
870.00
52 wk Range
585.00
1,002.40
AARTIPHARM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
858.00870.00
52 wk Range
585.001,002.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
AARTIPHARM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
740.00
Downside
-14.33%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 740.00
(-14.33% Downside)
Earnings
Latest Release
Aug 07, 2026
EPS / Forecast
8.39 / --
Revenue / Forecast
5.36B / --
Compare AARTIPHARM to Peers and Sector
Metrics to compare | AARTIPHARM | Peers Peers - average of corresponding metrics from companies closely matching AARTIPHARM: ITCHOTELS, BEML, CONCOR, AARTIDRUGS, INDGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAARTIPHARMPeersSector |
|---|---|---|---|---|
P/E Ratio | 38.2x | 33.8x | −0.3x | |
PEG Ratio | −1.65 | 0.54 | 0.00 | |
Price/Book | 3.7x | 3.2x | 2.6x | |
Price / LTM Sales | 4.0x | 3.6x | 2.9x | |
Upside (Analyst Target) | −14.7% | 19.6% | 64.3% | |
Fair Value Upside | Unlock | −0.6% | 10.0% | Unlock |
Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, ophthalmologic, antidepressant medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates, such as xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. It serves pharmaceutical, nutraceutical, and beverage industries. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Aarti Pharmalabs (AARTIPHARM) Stock Price Today?
The Aarti Pharmalabs stock price today is 863.80 INR.
What Stock Exchange Does Aarti Pharmalabs Trade On?
Aarti Pharmalabs is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Aarti Pharmalabs?
The stock symbol for Aarti Pharmalabs is "AARTIPHARM."
Does Aarti Pharmalabs Pay Dividends? What’s The Current Dividend Yield?
The Aarti Pharmalabs dividend yield is 0.4%%.
What Is the Aarti Pharmalabs Market Cap?
As of today, Aarti Pharmalabs market cap is 78.33B INR.
What Is Aarti Pharmalabs's Earnings Per Share (TTM)?
The Aarti Pharmalabs EPS (TTM) is 22.59.
From a Technical Analysis Perspective, Is AARTIPHARM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Aarti Pharmalabs Stock Split?
Aarti Pharmalabs has split 0 times.
How Many Employees Does Aarti Pharmalabs Have?
Aarti Pharmalabs has 2421 employees.
What is the current trading status of Aarti Pharmalabs (AARTIPHARM)?
As of Oct 15, 2026, Aarti Pharmalabs (AARTIPHARM) is trading at a price of 863.80 INR, with a previous close of 863.80 INR. The stock has fluctuated within a day range of 858.00 INR to 870.00 INR, while its 52-week range spans from 585.00 INR to 1,002.40 INR.
What Is Aarti Pharmalabs (AARTIPHARM) Price Target According to Analysts?
The average 12-month price target for Aarti Pharmalabs is 740.00 INR, with a high estimate of 740 INR and a low estimate of 740 INR. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -14.33% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.